Savill Corrine

Track

Insider profile

Savill Corrine's trades of Cullinan Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
463.65
Quantity 37,908
Value US$1,834,412
Transaction date
Proposed sale
Price
13.07
Quantity 40,000
Value US$522,800
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-02 2024-02-01
PlS Planned sale
84,402 +38.6%
66.36
US$1,232,584 		84,402 +38.6% 66.36 US$1,232,584
2024-02-01 2024-02-01
PrS Proposed sale
37,908
463.65
US$1,834,412 		37,908 463.65 US$1,834,412
2024-01-30 2024-01-29
PlS Planned sale
35,211 -0.7%
489.85
US$3,918,564 		35,211 -0.7% 489.85 US$3,918,564
2024-01-29 2024-01-29
PrS Proposed sale
40,000
13.07
US$522,800 		40,000 13.07 US$522,800
2024-01-24 2024-01-23
PlS Planned sale
21,316 -11.4%
12.46
US$265,597 		21,316 -11.4% 12.46 US$265,597
2024-01-24 2024-01-22
PlS Planned sale
4,125 -2.4%
12.02
US$49,582 		4,125 -2.4% 12.02 US$49,582
2024-01-24 2024-01-22
PlS Planned sale
14,559 -7.9%
12.18
US$177,329 		14,559 -7.9% 12.18 US$177,329
2024-01-22 2024-01-22
PrS Proposed sale
40,000
11.51
US$460,400 		40,000 11.51 US$460,400
2022-07-21 2022-07-19
PlS Planned sale
14,958 -9.1%
15.22
US$227,661 		14,958 -9.1% 15.22 US$227,661
2022-07-21 2022-07-18
PlS Planned sale
5,042 -3.0%
15.06
US$75,933 		5,042 -3.0% 15.06 US$75,933
2022-07-12 2022-07-11
PlS Planned sale
200 -0.1%
13.85
US$2,770 		200 -0.1% 13.85 US$2,770
2022-07-12 2022-07-11
PlS Planned sale
39,800 -19.0%
13.33
US$530,534 		39,800 -19.0% 13.33 US$530,534